Trials / Completed
CompletedNCT06139380
Intranasal Ketamine Effectiveness in Reducing Intramuscular Injection Pain Before Sedation Among Children
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 84 (actual)
- Sponsor
- Tehran University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 12 Months – 7 Years
- Healthy volunteers
- Not accepted
Summary
Hypothesis: Intranasal administration of ketamine would reduce the intramuscular pain of ketamine injection in children who undergo procedural sedation and analgesia in the emergency department.
Detailed description
Ketamine is a well-known medication in children's procedural sedation and analgesia. While it provides good analgesia along with sedation, its injection is painful and causes distress in children. Intranasal administration of Ketamine would reduce the intramuscular pain of ketamine injection in children who undergo procedural sedation and analgesia in the emergency department. This will also assess if intranasal administration would affect the depth of sedation and hospital length of stay of this group of patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketamine | This is medication which is commonly used for sedation in the emergency department. At the analgesic dose, this medication can be used to reduce the pain via other routes such as intranasal. |
| DRUG | Sterile water | Intranasal sterile water was administered via syringe. |
Timeline
- Start date
- 2023-12-02
- Primary completion
- 2024-04-28
- Completion
- 2024-05-31
- First posted
- 2023-11-18
- Last updated
- 2024-06-04
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT06139380. Inclusion in this directory is not an endorsement.